FRE Fresenius SE & Co. KGaA
43.87EUR+0.53%Mkt Cap: 26.85B $P/E: 15.841d ago
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fr…
Industry Peers
Medical Care Facilities$96.48BUSDP/E 14.6
$20.89BUSDP/E 10.0
$11.75BUSDP/E 12.1
$12.05BUSDP/E 11.7
$11.93BUSDP/E 20.2
$11.47BUSDP/E 15.1
$10.38BUSDP/E 7.2
$10.08BUSDP/E 27.1
$6.76BUSDP/E 25.0
$6.68BUSDP/E 25.7
$4.65BUSDP/E 94.0
$4.62BUSDP/E 23.4
$3.77BUSDP/E 42.5
$3.61BUSDP/E 25.9
$3.50BUSDP/E 17.7
$2.70BUSDP/E 9.8
$2.69BUSD
$2.67BUSDP/E 40.9
$2.51BUSD
$2.12BUSDP/E 12.5
| Headline | Source | Time |
|---|---|---|
Yesterday | ||
Older | ||
BBörse Online | ||
 Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | ||
 All You Need to Know About Fresenius SE & Co. (FSNUY) Rating Upgrade to Buy Fresenius SE & Co. (FSNUY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | ||